First Application of Genetically Modified, Live-cell, Pig Skin to a Human Wound

October 11, 2019

XenoTherapeutics, Inc., a regenerative medicine company specializing in xenotransplantation, received the Burke/Yannas Award for Best Bioengineering Paper today at the 51st conference of the American Burn Association for its research of Xeno-Skin™. Co-founders Paul Holzer, CEO and Jon Adkins, COO, accepted the award on the company’s behalf.

Contact Us

359 Newbury Street, 5th Floor Suite 526

Boston, MA 02115


Connect with us

Federal EIN Number: 81-1016095

© 2020 by XenoTherapeutics Foundation

  • Black Facebook Icon
  • Black Twitter Icon
  • LinkedIn